Tocqueville Opportunity Is One Of The Best Mid-Cap Funds This Year [Forbes]
Sage Therapeutics, Inc. (SAGE)
Last sage therapeutics, inc. earnings: 2/27 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.sagerx.com/investor-relations
Company Research
Source: Forbes
Tocqueville Opportunity Is One Of The Best Mid-Cap Funds This Year Thomas Vandeventer, portfolio manager of the Tocqueville Opportunity Fund Mutual fund manager Thomas Vandeventer marches to his own drummer. It seems to be working. The fund Vandeventer runs, The Tocqueville Opportunity Fund (TOPPX), is up 36% year to date, according to Morningstar, blowing away the 25.1% on its benchmark, the Russell Mid Cap Growth Index. And while the fund primarily holds small- and mid-cap stocks, it's posting a return more than double large-cap indexes such as the S&P 500 and the Russell 1000. The fund, which has 92 million in assets under management, beat its benchmark on an annualized basis for the three-year period 18.3% vs. 14.4%, and the 5-year period, 11.9% vs. 10.6%, according to Morningstar. Vandeventer uses his own multi-factor screen, which he runs on a monthly basis, looking for companies that possess the potential to deliver above-average long-term earnings growth. "It has a very elegan
Show less
Read more
Impact Snapshot
Event Time:
SAGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SAGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SAGE alerts
High impacting Sage Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
SAGE
News
- Sage Therapeutics (SAGE) Surges 12.2%: Is This an Indication of Further Gains? [Yahoo! Finance]Yahoo! Finance
- Sage Therapeutics, Inc. (NASDAQ: SAGE) had its price target lowered by analysts at Stifel Nicolaus from $10.00 to $6.00. They now have a "hold" rating on the stock.MarketBeat
- Yahoo Finance [Yahoo! Finance]Yahoo! Finance
- Sage Therapeutics to Present at the Piper Sandler 36th Annual Healthcare ConferenceBusiness Wire
- Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More [Yahoo! Finance]Yahoo! Finance
SAGE
Earnings
- 10/29/24 - Miss
SAGE
Sec Filings
- 12/13/24 - Form 144
- 11/26/24 - Form 8-K
- 11/20/24 - Form 8-K
- SAGE's page on the SEC website